Search results for "PULMONARY"

showing 10 items of 3030 documents

Efficacy Of Varenicline In Smokers With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtychemistry.chemical_compoundchemistrybusiness.industryInternal medicinemedicinePulmonary diseaseVareniclinebusinessB46. INHALED AND SYSTEMIC ANTI-INFLAMMATORY THERAPY IN COPD
researchProduct

Management of Venous Thromboembolism (VTE) in Patients with Acute Leukemia: Results from a Multicenter Study

2014

Abstract Background In the last decades, evaluation of thrombotic complications secondary to acute leukemia (AL) has been poorly investigated. Only scant data are available on management and prevention of thrombosis in this setting. We performed a multicenter retrospective study with the aim to evaluate the management of venous thromboembolism (VTE) in patients with AL and to report the most commonly adopted regimens of treatment. Materials and methods Available clinical records of out and in-patients diagnosed with AL from January 2008 to June 2013 in 7 Reference Regional Hospitals were analyzed. Cases of VTE, including thrombosis in atypical sites [Retinal occlusion (RO) and Cerebral Sinu…

medicine.medical_specialtyeducation.field_of_studyAcute leukemiabusiness.industrymedicine.drug_classDeep veinImmunologyPopulationLow molecular weight heparinRetrospective cohort studyCell BiologyHematologyFondaparinuxmedicine.diseaseBiochemistrySurgeryPulmonary embolismmedicine.anatomical_structureInternal medicinemedicineMedical historybusinesseducationmedicine.drugBlood
researchProduct

Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study

2013

Abstract Background Venous thrombosis (VT) frequently complicates the clinical course of cancer. Reported incidence of VT in many hematological neoplasms is up to 10%, a value comparable to that of solid tumors. Available data on the incidence and management of VT in Acute Leukemia (AL) are scanty and quite discordant. We have performed a multicenter retrospective study with the primary objective to evaluate the incidence of venous thrombotic complications in a population of patients with AL. Secondary objective was to evaluate the management of these complications in patients with AL. Materials and Methods Available clinical records of out and in-patients diagnosed with AL from January 200…

medicine.medical_specialtyeducation.field_of_studyAcute leukemiamedicine.drug_classbusiness.industryImmunologyAnticoagulantPopulationLow molecular weight heparinCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyThrombosisSurgeryPulmonary embolismVenous thrombosisInternal medicinemedicineFactor V LeidenbusinesseducationVenous Thromboembolism Acute Leukemia A Multicenter Study
researchProduct

Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised…

2017

Summary Background Superficial-vein thrombosis can lead to deep-vein thrombosis and pulmonary embolism. Rivaroxaban, an oral factor Xa inhibitor, might simplify treatment compared with fondaparinux because it does not require daily subcutaneous injection and is cheaper. We compared efficacy outcomes in patients with superficial-vein thrombosis and additional risk factors given either rivaroxaban or fondaparinux to assess whether rivaroxaban is non-inferior to fondaparinux in the prevention of thromboembolic complications. Methods In this open-label, masked endpoint, randomised, non-inferiority phase 3b trial, we recruited patients aged 18 years or older with symptomatic superficial-vein thr…

medicine.medical_specialtyeducation.field_of_studyRivaroxabanSuperficial vein thrombosisbusiness.industryPopulationHematology030204 cardiovascular system & hematologyFondaparinuxmedicine.diseaseThrombosislaw.inventionSurgeryPulmonary embolism03 medical and health sciences0302 clinical medicineRandomized controlled triallawMedicine030212 general & internal medicineThrombusbusinesseducationmedicine.drugThe Lancet Haematology
researchProduct

Ankle-Brachial Index as a Predictor of Cardiovascular Risk in Atrial Fibrillation

2012

Objectives: Atrial Fibrillation (AF), the most frequent sustained arrhythmia, is associated with a high rate of morbidity and mortality. The clinical course of AF is often complicated by cardiovascular and cerebrovascular adverse events that usually have a dual origin: cardio embolic and atherothrombotic. The aim of our study is to demonstrate the existence of a relationship between Systemic Atherosclerosis and AF. More specifically, we have analysed the prevalence of lower limb Peripheral Artery Disease (PAD) in a population of fibrillating patients, and we have assessed whether the coexistence of AF and PAD might result in increased cardiovascular risks. Methods: The study has been conduc…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationClinical courseAtrial fibrillationDiseasemedicine.diseaseOmicsPulmonary embolismmedicine.anatomical_structureInternal medicineCardiologyMedicinecardiovascular diseasesAnkleCardiology and Cardiovascular MedicinebusinessAdverse effecteducationJournal of Clinical & Experimental Cardiology
researchProduct

The Incidence of Audible Steam Pops Is Increased and Unpredictable With the ThermoCool® Surround Flow Catheter During Left Atrial Catheter Ablation: …

2015

Audible Steam Pops During Left Atrial Catheter AblationIntroduction Open irrigated radiofrequency (RF) ablation catheters with a porous tip (56 holes, TC-SF) permit delivering RF energy in a temperature-controlled mode without temperature rise. This prospective observational study investigated the association of different catheter parameters on the occurrence of audible steam pops during left atrial (LA) ablation. Methods and Results A total of 226 patients underwent TC-SF catheter ablation for atrial fibrillation. RF power delivery, impedance and catheter tip temperature were continually recorded throughout the ablation. Pulmonary vein isolation was performed with a maximum of 27 W and LA …

medicine.medical_specialtygenetic structuresbusiness.industrymedicine.medical_treatmentAtrial fibrillationCatheter ablationAblationmedicine.diseasePulmonary veinSurgeryCatheterLeft atrialPhysiology (medical)Internal medicineCardiac tamponademedicineCardiologyTamponadeCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Electrophysiology
researchProduct

Cardiac arrest in older adult patients

2021

Purpose of review To describe the epidemiology, prognostication, and treatment of out- and in-hospital cardiac arrest (OHCA and IHCA) in elderly patients. Recent findings Elderly patients undergoing cardiac arrest (CA) challenge the appropriateness of attempting cardiopulmonary resuscitation (CPR). Current literature suggests that factors traditionally associated with survival to hospital discharge and neurologically intact survival after CA cardiac arrest in general (e.g. presenting ryhthm, bystander CPR, targeted temperature management) may not be similarly favorable in elderly patients. Alternative factors meaningful for outcome in this special population include prearrest functional sta…

medicine.medical_specialtyhealth care facilities manpower and servicesmedicine.medical_treatmentMEDLINE030204 cardiovascular system & hematologyTargeted temperature management03 medical and health sciences0302 clinical medicineHypothermia InducedEpidemiologyMedicineHumansCardiopulmonary resuscitationAgedResuscitation OrdersAged 80 and overAdult patientsbusiness.industry030208 emergency & critical care medicinemedicine.diseaseComorbidityhumanitiesCardiopulmonary ResuscitationHeart ArrestAnesthesiology and Pain MedicineEmergency medicineFunctional statusRisk classificationbusinessOut-of-Hospital Cardiac Arrest
researchProduct

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension

2020

Abstract Background Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis (SSc), associated with a progressive elevation in pulmonary vascular resistance and subsequent right heart failure and death. Due to unspecific symptoms, the diagnosis of PAH is often delayed. On this basis, it is of great value to improve current diagnostic methods and develop new strategies for evaluating patients with suspected PAH. Interleukin-32 (IL-32) is a proinflammatory cytokine expressed in damaged vascular cells, and the present study aimed to assess if this cytokine could be a new biomarker of PAH during SSc. Methods The IL-32 expression was evaluated in the sera and skin sam…

medicine.medical_specialtylcsh:Diseases of the musculoskeletal systemHypertension Pulmonarymedicine.medical_treatment030204 cardiovascular system & hematologyPulmonary arterial hypertensionGastroenterologyProinflammatory cytokineSystemic sclerosi03 medical and health sciences0302 clinical medicineInternal medicinemedicine.arterysystemic sclerosis; pulmonary arterial hypertension; IL-32medicineHumansskin and connective tissue diseases030203 arthritis & rheumatologyScleroderma Systemicintegumentary systembusiness.industryInterleukinsRheumatologyInterleukin 32Cytokinemedicine.anatomical_structureIL-32; Pulmonary arterial hypertension; Systemic sclerosisIL-32Pulmonary arteryVascular resistanceSystemic sclerosisBiomarker (medicine)Immunohistochemistrylcsh:RC925-935businessBiomarkersResearch ArticleArthritis Research & Therapy
researchProduct

Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD

2020

Poor performance in the 6-min walk test (6MWT &lt

medicine.medical_specialtylcsh:MedicinePulmonary diseaseLogistic regressionArticlemobility activities03 medical and health sciences0302 clinical medicineInternal medicine6MWTMedicineCOPDIn patient030212 general & internal medicinePrognostic modelsCOPDPerformance statusbusiness.industrylcsh:RGeneral Medicinemedicine.disease5STSpredictors030228 respiratory systemTest scorebusiness6 min walking testJournal of Clinical Medicine
researchProduct

Thrombendarteriektomie bei chronischer thromboembolischer pulmonaler Hypertonie: Hämodynamik und Rechtsherzfunktion im Langzeitverlauf

2008

OBJECTIVE To find out whether pulmonary thromboendarterectomy (PTE) can achieve lasting reduction of pulmonary vascular resistance in patients with pulmonary arterial hypertension due to chronic thromboembolism. PATIENTS AND METHODS 45 patients (25 women, 20 men; mean age 45 +/- 24 [19-67] years) were re-investigated a mean of 21 (13-32) months after successful PTE. Two patients had then been in New York Heart Association (NYHA) stage II, 26 in stage III, and 17 in stage IV. In addition to clinical examination and chest radiogram 36 patients had right heart catheterization, 28 pulmonary angiography and 44 echocardiography. RESULTS Definite improvement of symptoms had occurred in all. 34 wer…

medicine.medical_specialtymedicine.diagnostic_testPulmonary thromboendarterectomybusiness.industrymedicine.medical_treatmentCardiac indexPhysical examinationGeneral MedicineStage iilaw.inventionmedicine.anatomical_structurelawInternal medicinemedicineVascular resistancePulmonary angiographyCardiologyStage (cooking)RadiogrambusinessDMW - Deutsche Medizinische Wochenschrift
researchProduct